Institutional Ownership
Syndax Pharmaceuticals Inc
CUSIP 87164F105COMSNDXQ1 2026
13D / 13G Filings
63
Schedule 13D/13G on record
Beneficial Filers
22
Distinct reporting persons
Largest Stake
11.7%
Max % of class reported
Institutional Holders
237
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
63 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | State Street Corporation | 13G | 5.3% | 4.60M | SEC |
| 2 | Jan 30, 2026 | The Vanguard Group | 13G/A | 7.2% | 6.23M | SEC |
| 3 | Aug 18, 2025 | Point72 Asset Management, L.P. | 13G | 5.0% | 4.33M | SEC |
| 4 | Aug 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 2.7% | 2.31M | SEC |
| 5 | Aug 13, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 5.58M | SEC |
| 6 | May 9, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 4.51M | SEC |
| 7 | May 7, 2025 | Morgan Stanley | 13G/A | 2.4% | 2.04M | SEC |
| 8 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.8% | 6.74M | SEC |
| 9 | Mar 7, 2025 | Wellington Management Group LLP | 13G/A | 0.0% | 35.7K | SEC |
| 10 | Feb 14, 2025 | Kynam Capital Management, LP | 13G/A | 10.0% | 8.52M | SEC |
53 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Syndax Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 8.25M | $192.82M |
| 2 | Kynam Capital Management, LP | 8.05M | $188.07M |
| 3 | Goldman Sachs Group Inc | 5.00M | $116.72M |
| 4 | State Street Corp | 4.43M | $103.49M |
| 5 | Bank Of America Corp /De/ | 4.25M | $99.28M |
| 6 | Deerfield Management Company, L.P. | 3.78M | $88.30M |
| 7 | Eversept Partners, LP | 2.89M | $67.41M |
| 8 | Kingdon Capital Management, L.L.C. | 2.50M | $58.40M |
| 9 | Hood River Capital Management LLC | 2.35M | $55.00M |
| 10 | Geode Capital Management, LLC | 2.16M | $50.40M |